Difference between revisions of "Zhou B, et al. J. Clin. Invest. (2014) cited as Ref 334 in DOI: 10.1038/s41392-020-0110-5 (Q9597)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: DOI Identifier (P138): 10.1172/JCI69804, #quickstatements; #temporary_batch_1590000649558)
(‎Created claim: Page(s) (P105): 553-563, #quickstatements; #temporary_batch_1590074839150)
 
(5 intermediate revisions by the same user not shown)
Property / PubMed ID
 +
Property / PubMed ID: 24435044 / rank
 +
Normal rank
Property / Publication Date
 +
2014
Timestamp+2014-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2014 / rank
 +
Normal rank
Property / Published In Name String
 +
J. Clin. Invest.
Property / Published In Name String: J. Clin. Invest. / rank
 +
Normal rank
Property / Volume
 +
124
Property / Volume: 124 / rank
 +
Normal rank
Property / title
 +
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal (English)
Property / title: Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal (English) / rank
 +
Normal rank
Property / Page(s)
 +
553-563
Property / Page(s): 553-563 / rank
 +
Normal rank

Latest revision as of 15:38, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Zhou B, et al. J. Clin. Invest. (2014) cited as Ref 334 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Zhou B
    0 references
    0 references
    2014
    0 references
    J. Clin. Invest.
    0 references
    124
    0 references
    Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal (English)
    0 references
    553-563
    0 references